Register Now!
Virtual Conference
Sept. 29 - Oct. 3, 2021
The late breaker abstract submission site is now open. Submit your late breaker abstract by August 18.
There is still time to submit your abstract or case for IDWeek 2021!
Abstract submission for IDWeek 2021 is now closed.
Case submission for IDWeek 2021 is now closed.
Day 1 – Day 2: Sept 29 – 30
Sept. 29-30: All Day
Sept. 29: 8–10 a.m.
Sept. 30: 10–11 a.m.
Edward H. Kass Lecture
Maxwell Finland Lecture
Sept. 30: 11 a.m.–12:15 p.m.
Day 3 Oct. 1
Oct. 1: 8–8:45 a.m.
Oct. 1: 9–10 a.m.
SHEA Lectureship
Stanley A. Plotkin Lectureship in Vaccinology:
Oct. 1: 10–11:15 a.m.
Oct. 1: 10–11:15 a.m.
Program Details
Preview sessions and speakers in the Interactive Program.
Exhibitors
Exhibitor packages, programs, affiliated event opportunities.
CME/CPE/MOC
View the information on credits offered during IDWeek.
Premeeting Workshops
Register for a workshop during the online registration process.
Session Types
IDWeek consists of 10 session types. Learn more.
Program Committee
View our leaders and decision makers for IDWeek.
Centers for Disease Control and Prevention
The 19th Director of the Centers for Disease Control and Prevention and the 9th Administrator of the Agency for Toxic Substances and Disease Registry.
University of Chicago
Dr. Pamer received his MD degree from Case Western Reserve University Medical School and completed clinical training in Internal Medicine and Infectious Diseases at UCSD Medical Center.
Rochester General Hospital
Dr. Falsey has broadened her research to include numerous viral respiratory pathogens including influenza, coronaviruses, parainfluenza viruses and human metapneumovirus.
Bill & Melinda Gates Foundation
Prof. Klugman's work demonstrates pneumococcal conjugate vaccine efficacy in the developing world, has led to interventions that continue to save millions of lives especially in Africa and in Asia.
Rutgers Robert Wood Johnson Medical School
Dr. Whitley-Williams has published articles and several book chapters, served on national grant review committees, is the recipient of many awards, and has mentored many young pediatricians, residents and medical students.
University of California, San Francisco
Dr. Yokoe's research has focused on the development and evaluation of streamlined and reliable methods for performing surveillance for healthcare-associated infections, particularly surgical site infections and she is an investigator in the CDC’s Prevention Epicenters research program.
Albert Einstein College of Medicine
Dr. Herold directs a translational research program focused on the interactions between viruses and their host and using that knowledge to develops novel treatment and prevention strategies.
Pfizer Inc.
Dr. Gruber’s clinical research group has been responsible for global clinical research and development of now licensed pneumococcal conjugate, meningococcal conjugate, rLP2086 meningococcal B, and influenza vaccines, as well as investigational Staph aureus, C. difficile, HIV, RSV, parainfluenza and HSV vaccines.
National Institutes of Health Clinical Center
General Physician
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sed pharetra urna. Nunc a erat facilisis, faucibus lorem nec, tincidunt erat. .
IDWeek will be held in the San Diego Convention Center, located at 111 W. Harbor Dr., San Diego, CA 92101, from Sept. 29 to Oct. 3, 2021. IDWeek events will also take place in some nearby hotels.
Exhibitor packages, support programs, affiliated event opportunities including satellite symposia, and promotional options for reaching the attendees are expected to be available at the end of the first quarter of 2021.
Advancing Science, Improving Care